Body Surface Area Calculator

Body surface area (BSA) is the total external surface area of the human body measured in square meters. It sounds obscure, but it's one of the most important measurements in clinical medicine — drug doses, burn injury assessments, cardiac output calculations, and chemotherapy protocols all rely on BSA because it correlates better with metabolic rate and organ function than body weight alone, particularly for medications that distribute throughout body tissues.

BSA in Cardiac Medicine

Cardiac output (the volume of blood the heart pumps per minute) is normalized to BSA to create the "cardiac index" — a more meaningful comparison across patients of different sizes. Cardiac output in liters/minute ÷ BSA in m² = Cardiac Index (L/min/m²). Normal cardiac index is 2.5-4.0 L/min/m². A cardiac index below 2.2 L/min/m² typically indicates cardiogenic shock, regardless of the absolute cardiac output.

Valve area measurements also use BSA normalization. The indexed mitral valve area (mitral valve area ÷ BSA) helps determine severity of mitral stenosis independent of body size. An absolute valve area of 1.5 cm² might be borderline severe in a small person (low BSA) but mild in a large person (high BSA). Indexing to BSA provides body-size-corrected interpretation that guides treatment decisions.

Related Calculators

• BMI Calculator
• Body Fat Calculator
• Lean Body Mass Calculator

Why BSA Matters in Medicine

Weight-based dosing assumes that a heavier person always needs more drug — which is often true but not always accurate for drugs that distribute into lean tissue rather than fat. BSA-based dosing accounts for the fact that body surface area correlates more closely with organ size, blood volume, and metabolic function in most adults and children.

Chemotherapy is the most critical BSA application. Most cytotoxic agents are dosed in mg/m² (milligrams per square meter of body surface area) because the narrow window between therapeutic effect and toxic overdose requires precise calibration. An oncologist calculating the dose for carboplatin, doxorubicin, or cyclophosphamide uses the patient's BSA as the primary dosing parameter. Getting this calculation wrong — off by even a small amount — can mean either inadequate treatment efficacy or life-threatening toxicity.

Burn injury assessment uses BSA differently. The Rule of Nines divides the body into regions each representing 9% of total body surface area (or multiples of 9%): each arm = 9%, each leg = 18%, front torso = 18%, back torso = 18%, head = 9%, perineum = 1%. A burn affecting 36% of BSA (say, both legs) requires dramatically different fluid resuscitation, wound care, and prognosis than a 9% burn. The Parkland formula for burn fluid resuscitation uses BSA percentage: 4 mL × weight (kg) × % BSA burned = mL of fluid in first 24 hours.

BSA Calculation Formulas

Multiple BSA calculation formulas have been developed, each with slightly different algorithms optimized for different populations. The most commonly used in clinical practice:

DuBois and DuBois formula (1916): BSA (m²) = 0.007184 × Height (cm)^0.725 × Weight (kg)^0.425. This was the standard formula for most of the 20th century and remains widely used despite being developed from just 9 subjects — a remarkably small validation set for such a consequential calculation.

Mosteller formula (1987): BSA (m²) = √[(Height (cm) × Weight (kg)) / 3600]. This simplified formula is easier to calculate mentally and produces results within 2% of the DuBois formula for most adults. It's favored in clinical settings where quick estimation is needed.

Haycock formula (1978), developed specifically for children: BSA (m²) = 0.024265 × Height (cm)^0.3964 × Weight (kg)^0.5378. Pediatric BSA calculations require formulas validated in pediatric populations, as body proportions differ significantly from adults.

Boyd formula and Gehan-George formula provide alternatives that various clinical systems prefer. The practical reality: for most drug dosing purposes, the formula choice matters less than the accuracy of the input measurements (height and weight). A 2% difference between formulas is clinically insignificant compared to, say, a 5% error in weight measurement.

Calculating BSA for a Specific Patient

Example using the Mosteller formula: a patient weighing 78 kg and 175 cm tall. BSA = √[(175 × 78) / 3600] = √[13,650 / 3600] = √3.792 = 1.947 m². Using DuBois-DuBois: BSA = 0.007184 × 175^0.725 × 78^0.425 = 0.007184 × 56.97 × 8.578 = 3.513 m² — wait, let me recalculate. 175^0.725: 175 to the 0.725 power. Using natural log: e^(0.725 × ln(175)) = e^(0.725 × 5.165) = e^3.744 = 42.31. 78^0.425: e^(0.425 × ln(78)) = e^(0.425 × 4.357) = e^1.852 = 6.375. BSA = 0.007184 × 42.31 × 6.375 = 0.007184 × 269.7 = 1.938 m².

The two formulas give 1.947 m² and 1.938 m² — within 0.5% of each other for this patient. Standard adult BSA ranges: 1.5-1.8 m² for women, 1.7-2.0 m² for men. Average adult BSA is approximately 1.73 m² for women and 1.90 m² for men based on population studies.

Limitations and Practical Considerations

BSA formulas were developed primarily from white Western European populations. Research has suggested that these formulas may overestimate BSA in East Asian populations and underestimate it in populations with different body compositions. Some oncology protocols now use population-specific BSA correction factors, though this remains an evolving area of practice.

Morbid obesity creates challenges for BSA-based dosing. Very high body weights disproportionately increase BSA compared to lean body mass, which can lead to overdosing of drugs that don't actually distribute into adipose tissue. Many chemotherapy protocols use adjusted body weight or cap the BSA calculation at a maximum value for obese patients — a clinical judgment that varies by drug and institution.

BSA calculations are only as accurate as the input measurements. Hospital weight measurements are typically accurate; heights are often self-reported and systematically overestimated by 1-2 inches. For high-stakes BSA-dependent dosing, measured height in the clinical setting (not patient-reported) is essential. A 2-inch height overestimation can change calculated BSA by 2-3%, which may matter for narrow therapeutic index drugs.